These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24107887)

  • 61. [Pathology of the hemostatic system in the acute period of an ischemic stroke and the possibilities for its therapeutic correction].
    Shutov AA; Karakulova IuV; Chudinov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(1):45-9. PubMed ID: 8677718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Xerostomia. Diagnosis and treatment].
    Afanas'ev VV; Irmiiaev AA
    Stomatologiia (Mosk); 2004; 83(6):36-8. PubMed ID: 15602471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
    Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
    Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
    [No Abstract]   [Full Text] [Related]  

  • 64. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. International issues: acute ischemic stroke: an international experience.
    Colling M; Lioutas VA; Krishnan V
    Neurology; 2014 Nov; 83(19):e174-6. PubMed ID: 25367062
    [No Abstract]   [Full Text] [Related]  

  • 66. The association between hyperintense vessel sign and final ischemic lesion differ in its location.
    Kono T; Naka H; Nomura E; Hosomi N; Aoki S; Imamura E; Sueda Y; Nezu T; Mukai T; Ohshita T; Ohtsuki T; Wakabayashi S; Matsumoto M
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1337-43. PubMed ID: 24424335
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
    Murray V
    Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
    [No Abstract]   [Full Text] [Related]  

  • 68. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mild stroke and advanced age are the major reasons for exclusion from thrombolysis in stroke patients admitted within 4.5 hours.
    Liu Y; Zhao H; Zhou J; Wang Q; Chen Z; Luo N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1571-6. PubMed ID: 24582787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute ischemic stroke.
    Chiti A; Giorli E; Orlandi G
    N Engl J Med; 2007 Nov; 357(21):2203; author reply 2204. PubMed ID: 18032775
    [No Abstract]   [Full Text] [Related]  

  • 71. Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.
    Llull L; Laredo C; Renú A; Pérez B; Vila E; Obach V; Urra X; Planas A; Amaro S; Chamorro Á
    Stroke; 2015 Aug; 46(8):2162-7. PubMed ID: 26159792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window.
    Mitsias PD; Lu M; Silver B; Morris D; Ewing JR; Daley S; Lewandowski C; Katramados A; Papamitsakis NI; Ebadian HB; Zhao Q; Soltanian-Zadeh H; Hearshen D; Patel SC; Chopp M
    Neurology; 2005 Aug; 65(4):612-5. PubMed ID: 16116128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Complex network analysis on dynamic change regularity of combining use of Chinese and western medicine in 27,678 cases with ischemic stroke in acute phase].
    Yang W; Li Y; Sun LL; Xie YM; Guo CH; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4783-90. PubMed ID: 27245023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis].
    Katunina EA
    Eksp Klin Farmakol; 2005; 68(5):16-8. PubMed ID: 16277203
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
    von Kummer R; Albers GW; Mori E;
    Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH;
    Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
    Chukanova EI; Chukanova AS; Mamayeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
    Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
    Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic stroke].
    Yagudina RI; Kulikov AY; Krylov VA; Solovieva EY; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):60-68. PubMed ID: 31464291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.